metformin has been researched along with emodin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hann, SS; Hu, J; Tang, Q; Wu, J; Yang, L; Zhao, S; Zheng, F | 1 |
| Grdina, DJ; Miller, RC; Murley, JS; Rademaker, AW; Senlik, RR | 1 |
| Ma, C; Miao, W; Sun, R; Zhai, R | 1 |
| Chai, HC; Chua, KH; Lim, SK; Mahendran, R; Ong, KC | 1 |
1 review(s) available for metformin and emodin
| Article | Year |
|---|---|
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.
Topics: Antioxidants; Chalcones; Curcumin; Diterpenes; Diterpenes, Kaurane; Emodin; Epoxy Compounds; Estrogen Antagonists; Flavanones; Humans; Hypoglycemic Agents; Metformin; Phenanthrenes; Plant Extracts; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; Quercetin; Resveratrol | 2021 |
3 other study(ies) available for metformin and emodin
| Article | Year |
|---|---|
Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKα and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun.
Topics: AMP-Activated Protein Kinases; Cell Line, Tumor; Cell Proliferation; Emodin; Humans; Hypoglycemic Agents; Metformin; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Promoter Regions, Genetic; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-jun; Signal Transduction; Sp1 Transcription Factor; Transcriptional Activation | 2015 |
Altered expression of a metformin-mediated radiation response in SA-NH and FSa tumor cells treated under in vitro and in vivo growth conditions.
Topics: Acetylcysteine; Animals; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Emodin; Female; Metformin; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Suppressor Protein p53 | 2017 |
Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Drug Synergism; Emodin; Female; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2020 |